Search
for
Sort by
Research 571–600 of 1000+
- Lrig1-expression confers suppressive function to CD4+ cells and is essential for averting autoimmunity via the Smad2/3/Foxp3 axis
- Maintenance of Barrier Tissue Integrity by Unconventional Lymphocytes
- P63 targeted deletion under the FOXN1 promoter disrupts pre-and post-natal thymus development, function and maintenance as well as induces severe hair loss
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Conventional histopathology and new technologies in cutaneous mucinoses: Old diagnostic criteria and new therapeutic perspectives
- Role of <i>foxn1</i> in <i>Xenopus laevis</i> thymopoiesis.
- Lymphocytic Mural Folliculitis Resembling Epitheliotropic Lymphoma in Tigers (<i>Panthera tigris</i>)
- 0935 Unravelling the role of JAK3/TEC kinase signalling with ritlecitinib in alopecia areata lesional skin and alopecia areata-induced human hair follicles ex vivo
- Combination therapy with oral PUVA and corticosteroid for recalcitrant alopecia areata
- Two Clinically Unusual Cases of Folliculotropic Mycosis Fungoides: One with and the Other without Syringotropism
- Folliculotropic Mycosis Fungoides: Update on Diagnosis, Clinicopathological Stage, and Management
- MAIT Cells in COVID-19: Heroes, Villains, or Both?
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Thymic Stromal Lymphopoietin in Cutaneous Immune-Mediated Diseases
- Folate receptor β performs an immune checkpoint function in activated macrophages
- Overview of the Role of 308 Monochromatic Excimer Phototherapy for the Treatment of Alopecia Areata
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Hair follicle-derived melanocyte transplant as a promising treatment strategy for vitiligo
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- Identification of drug-specific public TCR driving severe cutaneous adverse reactions
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- SYK inhibitor entospletinib prevents ocular and skin GVHD in mice
- Human ClinicalPhenotype Associated with FOXN1 Mutations
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- The Multi-Faceted Role of Gut Microbiota in Alopecia Areata
- 3D spheroid culture synchronizes heterogeneous MSCs into an immunomodulatory phenotype with enhanced anti-inflammatory effects
- Pathologic Quiz Case: A Cutaneous Nodule on the Left Temple
- Summary of the Preceding Three Alopecia Areata Research Summits: What’s Past Is Prologue
- A Case of Idiopathic Follicular Mucinosis Treated Successfully with Cyclosporine.
- 1385 Characterizing the expression of metabolic markers in alopecia areata